Food and Drug Administration

July 20 (UPI) — Taylor Farms said late Sunday the Trump administration mistakenly informed it that a sample of its shredded iceberg lettuce tested positive for a parasite amid a multi-state outbreak that prompted the U.S.-based fresh-produce giant to initiate a recall of the salad staple distributed to 27 states.

The Food and Drug Administration reversed the finding Sunday, determining that the purported positive test for the microscopic Cyclospora parasite, which causes the intestinal illness cyclosporiasis, was a false positive.

“Today, FDA apologized to us,” the company said in a statement.

“Today, we were informed that FDA made a mistake.”

Taylor Farms had initiated the voluntary recall Friday after federal health investigators linked shredded iceberg lettuce sourced from central Mexico to a multi-state cyclosporiasis outbreak through a traceback investigation.

At least 1,644 people in five states have been infected, including 94 hospitalizations, since May 13, according to the U.S. Centers for Disease Control and Prevention, which said there have been no fatalities.

Federal health investigators have linked the illnesses to shredded iceberg lettuce served at Taco Bell locations in Indiana, Kentucky, Michigan, Ohio and West Virginia.

The FDA said Friday that its traceback investigation identified the supplier as Taylor Farms de Mexico. The company then initiated the voluntary recall.

On Saturday, federal investigators said a sample collected during targeted import surveillance tested positive for Cyclospora. The FDA said the produce was not part of the initial recall and investigators were working to identify whether any of the lot was available in commerce.

A day later, Taylor Farms said it was informed of the FDA’s “mistake.”

“To be clear, at this moment, the FDA has not identified a single positive product test result for Cyclospora,” it said.

The FDA told media it had discovered the false positive after rechecking the results of the purported positive sample.

“As of July 19, 2026, there are no confirmed positive sample results for product testing for Cyclospora,” the FDA said in a statement, NBC News reported.

Taylor Farms said it had completed the voluntary recall, which was limited to iceberg lettuce grown and processed in central Mexico, and that all of its other produce is available for purchase.

“Our thoughts remain with everyone who has fallen ill in this outbreak,” it said.

“We are committed to working with public health authorities as the ongoing outbreak investigation continues.”

July 17 (UPI) — Taylor Farms announced Friday it is removing all iceberg lettuce sourced from central Mexico from the U.S. market, after federal officials said they traced the cyclosporiasis outbreak that’s caused illness in thousands of people to lettuce supplied to Taco Bell restaurants in five states.

The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration said their investigators found the shredded iceberg lettuce came from Taylor Farms, a supplier that also sells salad kits in grocery stores.

In a statement, the company said it is voluntarily removing all of its Mexico-sourced iceberg lettuce, adding the outbreak is not associated with any of its salad kits.

“While the FDA traceback is indicating a specific independent farm that represents less than 1% of the U.S.’s iceberg lettuce supply as the potential source of the outbreak, we have removed all iceberg lettuce from the region indefinitely,” the company statement said.

The CDC’s website says not to eat “shredded iceberg lettuce served at Taco Bell locations in Indiana, Kentucky, Michigan, Ohio and West Virginia.”

More than 1,600 people have been confirmed ill with the bug.

The agencies did not name a supplier, but two people familiar with the inquiry told The Washington Post that investigators have identified Taylor Farms as the supplier.

“The investigation remains active, and additional states, restaurants, retailers or products may be identified as more information becomes available,” said Emily Hilliard, a spokesperson for the Health and Human Services Department.

“The signal we have gotten is that there is a very high percentage of people who got sick at Taco Bell, and when investigators asked what their menu items were in common, lettuce came up frequently,” one person familiar with the investigation said.

“Based on ongoing conversations with public health officials, and out of an abundance of caution, Taco Bell has taken immediate action to voluntarily remove potentially impacted lettuce from a supplier in select states,” Taco Bell Corp. said in a statement. “The affected ingredient from our supplier is being indefinitely removed from our supply chain nationwide and will be replaced within 24 hours in select states.”

Taylor Farms is a leading global producer of salads and healthy fresh foods, with production facilities across the United States, Canada, Mexico and Western Europe. The company has been linked to several outbreaks.

In November 2024, onions from Taylor Farms were tainted with E.Coli and sold at McDonald’s stores via Quarter Pounders burgers. About 100 people in 14 states were sickened. In December 2015, 19 people in 18 states were sickened with E. Coli after eating tainted celery supplied by the company to grocery stores. In August 2013, salad kits from Taylor Farms grown in Mexico were recalled after more than 360 people in Texas, Iowa and Nebraska became ill with cyclosporiasis. In February 2013, Taylor Farms recalled organic baby spinach products sold in 39 states for potential E. coli contamination, though there were no reports of illness.

July 16 (UPI) — U.S. Army medics in Europe said Thursday they are testing a new handheld diagnostic tool that can identify traumatic brain injuries in as little as 15 minutes.

Military officials predicted the new i-STAT Alinity device, made by Abbott Laboratories, can revolutionize the way medics can detect and treat such injuries quickly in the battlefield environment.

Rather than traditional methods of assessing brain injury or concussion by making subjective judgements based on questioning patients, the new device can yield objective information by measuring unique biomarkers that are present in the blood of the injured.

Lt. Col. Bradley Dengler, the neurosurgery consultant to the Army Surgeon General and director of the Military Traumatic Brain Injury Initiative at the Uniformed Services University, said the development of the i-STAT Alinity is a game-changer.

“This is probably the single most important advancement in traumatic brain injury care in the last 15 to 20 years,” he said in an Army release. “Historically, we’ve missed a lot of these injuries.”

Abbott Labs received clearance from the Food and Drug Administration to use the device with whole blood two years ago. The company says it allows doctors to help assess patients with suspected concussion at the bedside and obtain “lab-quality” results in 15 minutes.

Prior to that, the tests were only cleared for use with plasma or serum, requiring samples to be sent to a lab for processing and testing.

With that approval, the Army is now integrating the devices into air defense forward units under 10th Army Air and Missile Defense Command. These units were judged to be among the most likely to benefit from the devices because they often operate in far-flung locations, hours away from advanced medical facilities and sophisticated brain scanners.

The i-Stat device measures two biomarkers from the brain that may be released into the bloodstream indicating a possible brain injury — ubiquitin C-terminal hydrolase L1, or UCH-L1, and glial fibrillary acidic protein, or GFAP.

Dengler said the tests are extremely valuable because if the blood biomarkers are not elevated, there is a 99% chance that there is no bleeding in the brain.

That’s deemed a major improvement over the widely used Military Acute Concussion Evaluation, a 15-minute standardized cognitive assessment involving memory lists and concentration exercises.

July 10 (UPI) — The Centers for Disease Control and Prevention on Friday reported that well over 800 cases of a food-borne parasite have been confirmed by 31 states.

CDC officials were working with state and local health agencies to investigate clusters of cyclosporiasis cases in multiple states, some of which the Food and Drug Administration is working to trace and others that have not yet been linked to a common source, the agency said in an update.

Cyclosporiasis is a gastrointestinal disease caused by the parasite cyclospora, which can cause watery diarrhea, loss of appetite and weight loss, and in some cases require hospitalization, according to the CDC.

The parasite can be acquired when people eat or drink contaminated food or water and, although it can be spread year-round, it is considered to be a larger problem during the spring and summer months.

The current series of outbreaks has been tracked since at least mid-June, although the FDA lists its first investigation of cyclospora as staring June 3. With no product linked to the parasite or any other outbreak, the FDA is attempting to trace back to a source.

“Multiple jurisdictions have reported an increase of cases in the last two weeks compared to the same period in 2025,” the CDC said in the update.

“We assume a 6-week reporting lag between illness onset and case reporting to CDC,” the agency said. “Therefore, we anticipate that case counts will continue to rise as data are received.”

The CDC reported that as of July 9, it has confirmed 843 cases of the nationally notifiable disease in 31 states, with 86 hospitalizations, but officials said the agency is aware of at least 1,500 more cases that have not yet been confirmed as domestically acquired in the United States.

Among the states reporting cases and investigations, Michigan on July 4 reported that its confirmed cases increased to 572, a large increase from 170 on June 30.

Cyclospora infects the small intestine after contaminated food or drink is consumed, and symptoms of infection can be seen anywhere from two days to two weeks after exposure.

Overall, the infection is generally not life-threatening, but because of dehydration linked to frequent and sometimes explosive diarrhea — especially in younger or older people, and those with weakened immune systems — it may require hospitalization.

Outbreaks in the United States have previously been linked to bagged salad mixes and kits, fresh cilantro and basil, raspberries, snow peas, and green onions, health officials said.

July 9 (UPI) — The Food and Drug Administration on Thursday recalled more than 2.5 million bottles of eye drops because they may contain a “foreign substance.”

The nationwide recall was initiated by Lupin Pharmaceuticals on June 4 because of some type of foreign substance, though the company and the FDA have not identified it or how it got into the eye drops, MassLive and NJ.com reported.

The class II recall of the prednisolone acetate eye drops — used to reduce inflammation after eye surgery or for allergic and other conditions — is the second-highest risk recall for the agency because it may cause adverse consequences if used.

In a recall notice posted on its website on Thursday, the FDA said that the recall of more than 2.5 million bottles of Lupin’s prednisolone eye drops was because of the “presence of foreign substance.”

The affected bottles come in 5 mL, 10 mL and 15 mL quantities, and were produced by the India-based Lupin, which specializes in manufacturing generic pharmaceutical medications.

The FDA also cautions against simply pausing the use of these medications, suggesting that people who need to use them contact their eye doctor or pharmacist in order to properly react for their own conditions.

June 9 (UPI) — The U.S. Food and Drug Administration on Tuesday added bemotrizinol to the list of permitted active ingredients in over-the-counter sunscreens, the first addition to that list since the 1990s.

The Department of Health and Human Services “is advancing innovation by bringing a new sunscreen ingredient to the U.S. market for the first time in 20 years,” HHS Secretary Robert F.Kennedy Jr said. “Bemotrizinol has been used safely in Europe for decades, and FDA’s action will increase competition and consumer confidence in sunscreen products.

The FDA said the ingredient has low levels of absorption through the skin and into the body and is generally recognized as safe and effective for adults and children 6 months old and older.

The American Chemical Society said that BEMT blocks ultraviolet A and ultraviolet B light rays and was first used in sunscreens in the European Union in 2000, with Canada, Australia and some countries in Asia following suit soon after.

UV B rays have more energy, cause visible sunburns and are the ones blocked by most U.S. sunscreens today. However, UV A rays can also cause skin cancers, the American Cancer Society said. They also cause skin cells to age and can cause indirect damage to cells’ DNA. The ACS said about 95% of the UV rays that reach the ground are UV A rays.

The FDA said an over-the-counter monograph drug, such as a sunscreen product, can enter the market without an approved drug application if it meets certain requirements. DSM Nutritional Products LLC submitted an OTC monograph order request to add BEMT, at concentrations up to 6%, as a new active ingredient in the OTC monograph for sunscreens. The FDA proposed to add BEMT in December, and the public could submit comments through Jan. 26.

May 21 (UPI) — Eli Lilly said its weight loss drug, retatrutide, helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight.

Many of the people who lost that much weight were on the highest dose of retatrutide for up to two years, but the company said that the weekly injection was effective for weight loss across all doses of the drug.

Retatrutide affects three hormones — GLP-1 and GIP, each of which are targeted by similar weight loss drugs, and glucagon, which none of them targets — and could be best for people looking to lose larger amounts of weight, said the company’s chief scientific and product officer, Dan Skovronsky.

“We haven’t seen that level of weight loss before with these kinds of medicines,” Skovronsky said, referring to a group of drugs that includes Eli Lilly’s Zepbound.

“For some patients, 30% weight loss may be more than what they’re seeking,” he said. “For other patients, that may be what they need to get healthy. So, not everyone will go up to the highest dose level and stay on it for two years.”

The phase 3 trial included 2,339 people who were obese or overweight. They were evaluated after 1 1/2 years or two years having injections.

Those who received the highest dose lost an average of 70 pounds, roughly 28% of their body weight, after 1 1/2 years, with patients who were assessed after two years losing an average of 85 pounds, or 30.3% of their weight, the company reported.

Side effects from the drug were reported to be similar to other weight loss drugs, which include nausea, diarrhea and constipation, and some patients also experienced upper respiratory tract infections and a nerve condition called dysesthesia, the company said.

The side effects were also similar to those seen in phase 3 trials evaluating retatrutide for use against diabetes and a specific type of arthritis.

Eli Lilly has not yet applied to the Food and Drug Administration for approval of the drug for any of the three uses.

May 8 (UPI) — President Donald Trump intends to fire Food and Drug Administration Commissioner Marty Makary because he is frustrated with the agency.

Trump signed off on the decision to replace Makary as he has clashed with Trump, officials in the Department of Health and Human Services and other officials in the administration, multiple reports said on Friday.

The reports — from NBC News, The New York Times, The Wall Street Journal and The Washington Post — all were attributed to Trump administration sources who requested anonymity because they were not authorized to comment on the issue.

Makary, a former surgeon at Johns Hopkins, was confirmed to run the FDA in March 2025 on a vote the included two Democratic members of the Senate voting yes.

His nomination carried some controversy because, like several other Trump cabinet members and nominees, is a former Fox News contributor who preferred that society develop natural immunity to the virus that causes COVID-19 instead of the CDC’s preferred method of using vaccine-induced immunity during the pandemic.

The reports suggest that Makary has struggled to run the FDA as long-time staff have left the agency and a range of healthcare, pharmaceutical and advocacy groups have been highly critical of its actions.

The Department of Health and Human Services and Makary have not commented on the reports, and sources for all four news organizations noted that the plan could change if Trump changes his mind.